Develops drugs for autoimmune diseases.
Dec 2025Revenue $10.0M/yrExpenses $393M/yr
No trendCash runway ≈ 3.0 years from Jun 2026
Figures by year
When will Zenas BioPharma be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $10.0M and expenses $393M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $10.0M | $393M | −$383M |
| Dec 2024 | $5.00M | $169M | −$164M |
| Dec 2023 | $50.0M | $87.1M | −$37.1M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.